inuvair 100 µg/dose - 6 µg/dose druckgasinhalation, lösung
chiesi - formoterolfumarat-dihydrat; beclometasone dipropionate - druckgasinhalation, lösung - 100 µg/dose - 6 µg/dose - formoterolfumarat-dihydrat 6 µg/dosis; beclometasone dipropionate 100 µg/dose - formoterol and beclometasone
riarify (previously chf 5993 chiesi farmaceutici s.p.a.)
chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - erhaltungstherapie bei erwachsenen patienten mit mittelschwerer bis schwerer chronisch obstruktiver lungenerkrankung (copd), die nicht ausreichend durch eine kombination von einer inhalativen kortikosteroiden und einem langwirksamen beta2-agonisten behandelt werden (für auswirkungen auf die kontrolle der symptome und vorbeugung von exazerbationen siehe abschnitt 5.
beclometasone apotex 0,05 % nasenspray, suspension
apotex - beclometasone dipropionate - nasenspray, suspension - 0,05 % - beclometasone dipropionate 50 µg/dose - beclometasone
beclometasone/ formoterol cipla 200/6 mikrogramm/sprühstoß, druckgasinhalation, lösung
cipla europe - beclometasondipropionat, wasserfreies; formoterolfumarat dihydrat -
beclometasone/formoterol cipla 100/6 mikrogramm/sprühstoß, druckgasinhalation, lösung
cipla europe nv - beclometasondipropionat, wasserfreies; formoterolfumarat dihydrat -
inuvair 200 µg/dose - 6 µg/dose druckgasinhalation, lösung
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - druckgasinhalation, lösung - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone
inuvair nexthaler 100 µg/dose - 6 µg/dose pulver zur inhalation
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 100 µg/dose - 6 µg/dose - beclometasone dipropionate 100 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone
inuvair nexthaler 200 µg/dose - 6 µg/dose pulver zur inhalation
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone
inuvair nexthaler 200 µg/dose - 12 µg/dose pulver zur inhalation
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 200 µg/dose - 12 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 12 µg/dosis - formoterol and beclometasone
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarat dihydrat, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.